- Home
- ORIC vs EHAB Comparison
ORIC vs EHAB Comparison
Compare ORIC & EHAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ORIC
- EHAB
- Stock Information
- Founded
- ORIC 2014
- EHAB 2014
- Country
- ORIC United States
- EHAB United States
- Employees
- ORIC N/A
- EHAB N/A
- Industry
- ORIC Biotechnology: Pharmaceutical Preparations
- EHAB Hospital/Nursing Management
- Sector
- ORIC Health Care
- EHAB Health Care
- Exchange
- ORIC Nasdaq
- EHAB Nasdaq
- Market Cap
- ORIC 362.9M
- EHAB 405.4M
- IPO Year
- ORIC 2020
- EHAB N/A
- Fundamental
- Price
- ORIC $4.77
- EHAB $7.68
- Analyst Decision
- ORIC Strong Buy
- EHAB Hold
- Analyst Count
- ORIC 9
- EHAB 3
- Target Price
- ORIC $18.43
- EHAB $8.50
- AVG Volume (30 Days)
- ORIC 969.8K
- EHAB 311.6K
- Earning Date
- ORIC 05-05-2025
- EHAB 05-07-2025
- Dividend Yield
- ORIC N/A
- EHAB N/A
- EPS Growth
- ORIC N/A
- EHAB N/A
- EPS
- ORIC N/A
- EHAB N/A
- Revenue
- ORIC N/A
- EHAB $1,034,800,000.00
- Revenue This Year
- ORIC N/A
- EHAB $5.33
- Revenue Next Year
- ORIC N/A
- EHAB $4.86
- P/E Ratio
- ORIC N/A
- EHAB N/A
- Revenue Growth
- ORIC N/A
- EHAB N/A
- 52 Week Low
- ORIC $3.90
- EHAB $6.85
- 52 Week High
- ORIC $14.67
- EHAB $10.70
- Technical
- Relative Strength Index (RSI)
- ORIC 37.10
- EHAB 34.58
- Support Level
- ORIC $3.90
- EHAB $7.56
- Resistance Level
- ORIC $5.38
- EHAB $7.91
- Average True Range (ATR)
- ORIC 0.53
- EHAB 0.35
- MACD
- ORIC 0.06
- EHAB -0.08
- Stochastic Oscillator
- ORIC 41.97
- EHAB 9.42
About ORIC Oric Pharmaceuticals Inc.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
About EHAB Enhabit Inc.
Enhabit Inc provides home health and hospice services in the United States. Its reportable segments are Home Health and Hospice. The Home Health segment includes a comprehensive range of Medicare-certified home nursing services to adult patients in need of care. These services include, among others, skilled nursing, physical, occupational, and speech therapy, medical social work, and home health aide services. The Hospice segment focuses on the quality of life for patients who are experiencing an advanced, life-limiting illness while treating the person and symptoms of the disease, rather than the disease itself. The company generates a majority of its revenue from the Home Health segment.